HomeAboutProducts QualityPartners InsightsContact
Home/Products
Portfolio

A portfolio shaped by
clinical necessity.

We distribute 240+ pharmaceutical SKUs across six therapeutic areas — selected for their public-health impact, prescribed daily by physicians, and trusted by the patients who rely on them.

TA.01 · Cardiovascular

Antihypertensives

ACE inhibitors, ARBs and direct vasodilators for first- and second-line management of essential hypertension.

  • 14 SKUs Tablets · 30/100
  • Generics + Originator Rx
TA.01 · Cardiovascular

Statins & Lipid Management

Atorvastatin, rosuvastatin and combination therapies for hypercholesterolaemia and post-MI secondary prevention.

  • 9 SKUs Tablets
  • Originator + Generic Rx
TA.01 · Cardiovascular

Anticoagulants

DOACs, LMWH and VKA for atrial fibrillation, VTE prophylaxis and treatment.

  • 11 SKUs Oral · Injectable
  • Cold-chain capable Rx
TA.02 · Diabetes

Oral Antidiabetics

Metformin, sulfonylureas, DPP-4 inhibitors and SGLT2 inhibitors for type 2 diabetes management.

  • 16 SKUs Tablets
  • Generics + Originator Rx
TA.02 · Diabetes

Insulins & Analogues

Human insulin, rapid- and long-acting analogues, premixed formulations. Full cold-chain handled.

  • 8 SKUs Cartridges · Pens · Vials
  • 2–8°C Rx
TA.02 · Diabetes

GLP-1 Receptor Agonists

Injectable and once-weekly formulations for type 2 diabetes and chronic weight management.

  • 4 SKUs Pre-filled pens
  • Cold-chain Rx
TA.03 · CNS

Antidepressants

SSRIs, SNRIs, atypicals and adjunctive therapies for major depressive disorder and anxiety.

  • 14 SKUs Tablets · Capsules
  • Generics + Originator Rx
TA.03 · CNS

Antipsychotics

First- and second-generation antipsychotics including long-acting injectables for schizophrenia and bipolar disorder.

  • 12 SKUs Oral · LAI
  • Risk-management Rx
TA.03 · CNS

Anti-epileptics

Narrow- and broad-spectrum anticonvulsants for focal and generalised seizure disorders.

  • 10 SKUs Tablets · Oral solution
  • Generics + Originator Rx
TA.04 · Respiratory

Inhaled Therapies

ICS, LABA, LAMA and triple-combination inhalers for asthma and COPD maintenance.

  • 12 SKUs DPI · pMDI
  • Originator + Generic Rx
TA.04 · Respiratory

Antihistamines

Second-generation non-sedating antihistamines for allergic rhinitis and chronic urticaria.

  • 6 SKUs Tablets · Syrup
  • OTC + Rx Rx/OTC
TA.04 · Respiratory

Nasal Corticosteroids

Intranasal steroids for allergic and non-allergic rhinitis, including paediatric formulations.

  • 4 SKUs Sprays
  • OTC OTC
TA.05 · Gastroenterology

Proton Pump Inhibitors

Omeprazole, pantoprazole, esomeprazole and dexlansoprazole for GERD, PUD and H. pylori eradication.

  • 10 SKUs Capsules · Tablets · IV
  • Generics + Originator Rx/OTC
TA.05 · Gastroenterology

Hepatoprotectors

Ursodeoxycholic acid, silymarin and Essentiale formulations for chronic liver conditions.

  • 5 SKUs Capsules · Oral solution
  • Generics Rx/OTC
TA.05 · Gastroenterology

IBD Therapies

5-ASA, immunosuppressants and biologics for Crohn's disease and ulcerative colitis.

  • 3 SKUs Oral · Rectal
  • Specialty Rx
TA.06 · Oncology

Targeted Therapies

Tyrosine kinase inhibitors and monoclonal antibodies for solid tumours, handled in dedicated cold-chain protocols.

  • 7 SKUs Oral · IV infusion
  • Risk-management Specialty Rx
TA.06 · Oncology

Immunomodulators

Check-point inhibitors and supportive therapies managed by qualified pharmacists and oncology nurses.

  • 4 SKUs IV · SC
  • Cold-chain Specialty Rx
TA.06 · Oncology

Rare-Disease Medicines

Orphan-designated therapies distributed via named-patient and early-access programmes.

  • 3 SKUs Oral · Injectable
  • Named-patient Specialty Rx
Manufacturer inquiry

Looking for a partner in one of these areas?

If you are a manufacturer evaluating distribution for a molecule in our portfolio areas — or an adjacent one — we would be glad to share a confidential feasibility note.

Send dossier →
Get in touch

Discuss a partnership
with our BD team.

We respond to qualified manufacturer inquiries within two business days. Brief, transparent, no-nonsense — tell us about the molecule and the markets.

Request meeting → See our partners